Data for sequence comparison of commamox genomes and genes identified. This dataset is associated with the following publication: Camejo, P., J. Santodomingo, K. McMahon, and D. Noguera. Genome-enabled insights into the ecophysiology of the comammox bacterium Ca. Nitrospira nitrosa. ENVIRONMENTAL SCIENCE & TECHNOLOGY. American Chemical Society, Washington, DC, USA, 2(5): 1-16, (2017).

Subtitle

"Synthetic protein dataset with sequences, physical properties, and functional classification for machine learning tasks."

Description

Introduction

This synthetic dataset was created to explore and develop machine learning models in bioinformatics. It contains 20,000 synthetic proteins, each with an amino acid sequence, calculated physicochemical properties, and a functional classification.

Columns Included

• ID_Protein: Unique identifier for each protein.
• Sequence: String of amino acids.
• Molecular_Weight: Molecular weight calculated from the sequence.
• Isoelectric_Point: Estimated isoelectric point based on the sequence composition.
• Hydrophobicity: Average hydrophobicity calculated from the sequence.
• Total_Charge: Sum of the charges of the amino acids in the sequence.
• Polar_Proportion: Percentage of polar amino acids in the sequence.
• Nonpolar_Proportion: Percentage of nonpolar amino acids in the sequence.
• Sequence_Length: Total number of amino acids in the sequence.
• Class: The functional class of the protein, one of five categories: Enzyme, Transport, Structural, Receptor, Other.

Inspiration and Sources

While this is a simulated dataset, it was inspired by patterns observed in real protein datasets, such as: - UniProt: A comprehensive database of protein sequences and annotations. - Kyte-Doolittle Scale: Calculations of hydrophobicity. - Biopython: A tool for analyzing biological sequences.

Proposed Uses

This dataset is ideal for: - Training classification models for proteins. - Exploratory analysis of physicochemical properties of proteins. - Building machine learning pipelines in bioinformatics.

How This Dataset Was Created

1. Sequence Generation: Amino acid chains were randomly generated with lengths between 50 and 300 residues.
2. Property Calculation: Physicochemical properties were calculated using the Biopython library.
3. Class Assignment: Classes were randomly assigned for classification purposes.

Limitations

• The sequences and properties do not represent real proteins but follow patterns observed in natural proteins.
• The functional classes are simulated and do not correspond to actual biological characteristics.

Data Split

The dataset is divided into two subsets: - Training: 16,000 samples (proteinas_train.csv). - Testing: 4,000 samples (proteinas_test.csv).

Acknowledgment

This dataset was inspired by real bioinformatics challenges and designed to help researchers and developers explore machine learning applications in protein analysis.

Harvester is a Web-based tool that bulk-collects bioinformatic data on human proteins from various databases and prediction servers. It is a meta search engine for gene and protein information. It searches 16 major databases and prediction servers and combines the results on pregenerated HTML pages. In this way Harvester can provide comprehensive gene-protein information from different servers in a convenient and fast manner. As full text meta search engine, similar to Google trade mark, Harvester allows screening of the whole genome proteome for current protein functions and predictions in a few seconds. With Harvester it is now possible to compare and check the quality of different database entries and prediction algorithms on a single page. Sponsors: This work has been supported by the BMBF with grants 01GR0101 and 01KW0013.

The COVID-19 pandemic has shown that bioinformatics--a multidisciplinary field that combines biological knowledge with computer programming concerned with the acquisition, storage, analysis, and dissemination of biological data--has a fundamental role in scientific research strategies in all disciplines involved in fighting the virus and its variants. It aids in sequencing and annotating genomes and their observed mutations; analyzing gene and protein expression; simulation and modeling of DNA, RNA, proteins and biomolecular interactions; and mining of biological literature, among many other critical areas of research. Studies suggest that bioinformatics skills in the Latin American and Caribbean region are relatively incipient, and thus its scientific systems cannot take full advantage of the increasing availability of bioinformatic tools and data. This dataset is a catalog of bioinformatics software for researchers and professionals working in life sciences. It includes more than 300 different tools for varied uses, such as data analysis, visualization, repositories and databases, data storage services, scientific communication, marketplace and collaboration, and lab resource management. Most tools are available as web-based or desktop applications, while others are programming libraries. It also includes 10 suggested entries for other third-party repositories that could be of use.

🔭 Overview

  R2MED: First Reasoning-Driven Medical Retrieval Benchmark

R2MED is a high-quality, high-resolution synthetic information retrieval (IR) dataset designed for medical scenarios. It contains 876 queries with three retrieval tasks, five medical scenarios, and twelve body systems.

Dataset

Q

D

Avg. Pos Q-Len D-Len

Biology 103 57359 3.6 115.2 83.6

Bioinformatics77 47473 2.9 273.8 150.5

Medical Sciences 88 34810 2.8 107.1 122.7

MedXpertQA-Exam 97… See the full description on the dataset page: https://huggingface.co/datasets/R2MED/Bioinformatics.

Bioinformatics Services Market will grow from USD 4,399.58 Million to USD 16,297.10 Million by 2034, showing an impressive CAGR of 15.7%.

RNA expression analysis was performed on the corpus luteum tissue at five time points after prostaglandin F2 alpha treatment of midcycle cows using an Affymetrix Bovine Gene v1 Array. The normalized linear microarray data was uploaded to the NCBI GEO repository (GSE94069). Subsequent statistical analysis determined differentially expressed transcripts ± 1.5-fold change from saline control with P ≤ 0.05. Gene ontology of differentially expressed transcripts was annotated by DAVID and Panther. Physiological characteristics of the study animals are presented in a figure. Bioinformatic analysis by Ingenuity Pathway Analysis was curated, compiled, and presented in tables. A dataset comparison with similar microarray analyses was performed and bioinformatics analysis by Ingenuity Pathway Analysis, DAVID, Panther, and String of differentially expressed genes from each dataset as well as the differentially expressed genes common to all three datasets were curated, compiled, and presented in tables. Finally, a table comparing four bioinformatics tools' predictions of functions associated with genes common to all three datasets is presented. These data have been further analyzed and interpreted in the companion article "Early transcriptome responses of the bovine mid-cycle corpus luteum to prostaglandin F2 alpha includes cytokine signaling". Resources in this dataset:Resource Title: Supporting information as Excel spreadsheets and tables. File Name: Web Page, url: http://www.sciencedirect.com/science/article/pii/S2352340917304031?via=ihub#s0070

Snapshot img

Bioinformatics Market Size 2025-2029

The bioinformatics market size is valued to increase by USD 15.98 billion, at a CAGR of 17.4% from 2024 to 2029. Reduction in cost of genetic sequencing will drive the bioinformatics market.

Market Insights

North America dominated the market and accounted for a 43% growth during the 2025-2029.
By Application - Molecular phylogenetics segment was valued at USD 4.48 billion in 2023
By Product - Platforms segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 309.88 million 
Market Future Opportunities 2024: USD 15978.00 million
CAGR from 2024 to 2029 : 17.4%

Market Summary

The market is a dynamic and evolving field that plays a pivotal role in advancing scientific research and innovation in various industries, including healthcare, agriculture, and academia. One of the primary drivers of this market's growth is the rapid reduction in the cost of genetic sequencing, making it increasingly accessible to researchers and organizations worldwide. This affordability has led to an influx of large-scale genomic data, necessitating the development of sophisticated bioinformatics tools for Next-Generation Sequencing (NGS) data analysis. Another significant trend in the market is the shortage of trained laboratory professionals capable of handling and interpreting complex genomic data. This skills gap creates a demand for user-friendly bioinformatics software and services that can streamline data analysis and interpretation, enabling researchers to focus on scientific discovery rather than data processing. For instance, a leading pharmaceutical company could leverage bioinformatics tools to optimize its drug discovery pipeline by analyzing large genomic datasets to identify potential drug targets and predict their efficacy. By integrating these tools into its workflow, the company can reduce the time and cost associated with traditional drug discovery methods, ultimately bringing new therapies to market more efficiently. Despite its numerous benefits, the market faces challenges such as data security and privacy concerns, data standardization, and the need for interoperability between different software platforms. Addressing these challenges will require collaboration between industry stakeholders, regulatory bodies, and academic institutions to establish best practices and develop standardized protocols for data sharing and analysis.

What will be the size of the Bioinformatics Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free SampleBioinformatics, a dynamic and evolving market, is witnessing significant growth as businesses increasingly rely on high-performance computing, gene annotation, and bioinformatics software to decipher regulatory elements, gene expression regulation, and genomic variation. Machine learning algorithms, phylogenetic trees, and ontology development are integral tools for disease modeling and protein interactions. cloud computing platforms facilitate the storage and analysis of vast biological databases and sequence datas, enabling data mining techniques and statistical modeling for sequence assembly and drug discovery pipelines. Proteomic analysis, protein folding, and computational biology are crucial components of this domain, with biomedical ontologies and data integration platforms enhancing research efficiency. The integration of gene annotation and machine learning algorithms, for instance, has led to a 25% increase in accurate disease diagnosis within leading healthcare organizations. This trend underscores the importance of investing in advanced bioinformatics solutions for improved regulatory compliance, budgeting, and product strategy.

Unpacking the Bioinformatics Market Landscape

Bioinformatics, an essential discipline at the intersection of biology and computer science, continues to revolutionize the scientific landscape. Evolutionary bioinformatics, with its molecular dynamics simulation and systems biology approaches, enables a deeper understanding of biological processes, leading to improved ROI in research and development. For instance, next-generation sequencing technologies have reduced sequencing costs by a factor of ten, enabling genome-wide association studies and transcriptome sequencing on a previously unimaginable scale. In clinical bioinformatics, homology modeling techniques and protein-protein interaction analysis facilitate drug target identification, enhancing compliance with regulatory requirements. Phylogenetic analysis tools and comparative genomics studies contribute to the discovery of novel biomarkers and the development of personalized treatments. Bioimage informatics and proteomic data integration employ advanced sequence alignment algorithms and functional genomics tools to unlock new insights from complex

gedepir is an R package that simplifies the use of deconvolution tools within a complete transcriptomics analysis pipeline. It simplify the definition of a end-to-end analysis pipeline with a set of base functions that are connected through the pipes syntax used in magrittr, tidyr or dplyrR packages

Survey participant demographics (total number of responses: 72).

Database of curated links to molecular resources, tools and databases selected on the basis of recommendations from bioinformatics experts in the field. This resource relies on input from its community of bioinformatics users for suggestions. Starting in 2003, it has also started listing all links contained in the NAR Webserver issue. The different types of information available in this portal: * Computer Related: This category contains links to resources relating to programming languages often used in bioinformatics. Other tools of the trade, such as web development and database resources, are also included here. * Sequence Comparison: Tools and resources for the comparison of sequences including sequence similarity searching, alignment tools, and general comparative genomics resources. * DNA: This category contains links to useful resources for DNA sequence analyses such as tools for comparative sequence analysis and sequence assembly. Links to programs for sequence manipulation, primer design, and sequence retrieval and submission are also listed here. * Education: Links to information about the techniques, materials, people, places, and events of the greater bioinformatics community. Included are current news headlines, literature sources, educational material and links to bioinformatics courses and workshops. * Expression: Links to tools for predicting the expression, alternative splicing, and regulation of a gene sequence are found here. This section also contains links to databases, methods, and analysis tools for protein expression, SAGE, EST, and microarray data. * Human Genome: This section contains links to draft annotations of the human genome in addition to resources for sequence polymorphisms and genomics. Also included are links related to ethical discussions surrounding the study of the human genome. * Literature: Links to resources related to published literature, including tools to search for articles and through literature abstracts. Additional text mining resources, open access resources, and literature goldmines are also listed. * Model Organisms: Included in this category are links to resources for various model organisms ranging from mammals to microbes. These include databases and tools for genome scale analyses. * Other Molecules: Bioinformatics tools related to molecules other than DNA, RNA, and protein. This category will include resources for the bioinformatics of small molecules as well as for other biopolymers including carbohydrates and metabolites. * Protein: This category contains links to useful resources for protein sequence and structure analyses. Resources for phylogenetic analyses, prediction of protein features, and analyses of interactions are also found here. * RNA: Resources include links to sequence retrieval programs, structure prediction and visualization tools, motif search programs, and information on various functional RNAs.

Ameloblastoma is a highly aggressive odontogenic tumor, and its pathogenesis is associated with multiple participating genes. Objective: Our aim was to identify and validate new critical genes of conventional ameloblastoma using microarray and bioinformatics analysis. Methods: Gene expression microarray and bioinformatic analysis were performed to use CHIP H10KA and DAVID software for enrichment. Protein-protein interactions (PPI) were visualized using STRING-Cytoscape with MCODE plugin, followed by Kaplan-Meier and GEPIA analysis that were employed for the candidate's postulation. RT-qPCR and IHC assays were performed to validate the bioinformatic approach. Results: 376 upregulated genes were identified. PPI analysis revealed 14 genes that were validated by Kaplan-Meier and GEPIA resulting in PDGFA and IL2RA as candidate genes. The RT-qPCR analysis confirmed their intense expression. Immunohistochemistry analysis showed that PDGFA expression is parenchyma located. Conclusion: With bioinformatics methods, we can identify upregulated genes in conventional ameloblastoma, and with RT-qPCR and immunoexpression analysis validate that PDGFA could be a more specific and localized therapeutic target.

Bioinformatics services market size is expected to grow from USD 3.49 bn in 2024 to USD 4.09 bn in 2025 and USD 14.94 bn by 2035, representing a CAGR of 13.8%

The size of the Bioinformatics Platforms Market market was valued at USD 16.36 Million in 2023 and is projected to reach USD 27.93 Million by 2032, with an expected CAGR of 7.94% during the forecast period. Recent developments include: In June 2022, California's biotechnology research startup LatchBio launched an end-to-end bioinformatics platform for handling big biotech data to accelerate scientific discovery., In March 2022, ARUP launched Rio, a bioinformatics pipeline and analytics platform for better, faster next-generation sequencing test results.. Key drivers for this market are: Increasing Demand for Nucleic Acid and Protein Sequencing, Increasing Initiatives from Governments and Private Organizations; Accelerating Growth of Proteomics and Genomics; Increasing Research on Molecular Biology and Drug Discovery. Potential restraints include: Lack of Well-defined Standards and Common Data Formats for Integration of Data, Data Complexity Concerns and Lack of User-friendly Tools. Notable trends are: Sequence Analysis Platform Segment is Expected Hold a Significant Share Over the Forecast Period.

Table. 1. Recent Bioinformatics Tools for Discovery, Prediction, and Analysis of Natural Product Pathways. (2020–2024).

Commented custom scripts for bioinformatics, analysis and producing figures. See Readme.txt file for a full description of each script.

Pecan scab, caused by the fungal pathogen Venturia effusa, is the most devastating disease of pecan (Carya illinoinensis) in the southeastern United States. Resistance to this pathogen is determined by a complex interaction between host genetics and disease pathotype with even field-susceptible cultivars being resistant to most scab isolates. To understand the underlying molecular mechanisms of scab resistance in pecan, we performed a transcriptome analysis of the pecan cultivar, ‘Desirable’, in response to inoculation with a pathogenic and a non-pathogenic scab isolate at three different time points (24, 48, and 96 hrs. post-inoculation). Differential gene expression and gene ontology enrichment analyses showed contrasting gene expression patterns and pathway enrichment in response to the contrasting isolates with varying pathogenicity. The weighted gene co-expression network analysis of differentially expressed genes detected 11 gene modules. Among them, two modules had significant enrichment of genes involved with defense responses. These genes were particularly upregulated in the resistant reaction at the early stage of fungal infection (24 h) compared to the susceptible reaction. Hub genes in these modules were predominantly related to receptor-like protein kinase activity, signal reception, signal transduction, biosynthesis and transport of plant secondary metabolites, and oxidoreductase activity. Results of this study suggest that the early response of pathogen-related signal transduction and development of cellular barriers against the invading fungus are likely defense mechanisms employed by pecan cultivars against non-virulent scab isolates. The transcriptomic data generated here provide the foundation for identifying candidate resistance genes in pecan against V. effusa and for exploring the molecular mechanisms of disease resistance.

Input,parameter, movie files of Zein Protein Bioinformatics structural and conformational MD Simulation studies

Virus reads reported by the bioinformatic pipeline.

The size of the Bioinformatics Market was valued at USD 20.72 USD Billion in 2023 and is projected to reach USD 64.45 USD Billion by 2032, with an expected CAGR of 17.6% during the forecast period. Recent developments include: October 2023 – Bionl, Inc., a pioneering company in biomedical and bioinformatics research, launched a no-code biomedical research platform that enables researchers, students, and professionals to investigate biomedicine using natural language queries., October 2023 – BioBam Bioinformatics launched OmicsBox 3.1 to empower researchers, scientists, and bioinformaticians in their pursuit of advanced omics data analysis and interpretation., April 2023 – Absci Corp. collaborated with Aster Insights (formerly named M2GEN) to expedite the development of new cancer medicines., December 2022 – Analytical Biosciences Limited partnered with Mission Bio to co-develop bioinformatics packages for translational and clinical research applications in hematological cancers., April 2022 – ATCC signed an agreement with QIAGEN to provide sequencing data from its collection of biological data. QIAGEN Digital Insights aims to establish a database from this information to develop and deliver high-value digital biology content for the biotechnology and pharmaceutical industries.. Key drivers for this market are: Increased Funding for Genomics Research to Surge Demand for Bioinformatic Solutions. Potential restraints include: Increased Funding for Genomics Research to Surge Demand for Bioinformatic Solutions. Notable trends are: Increased Funding for Genomics Research to Surge Demand for Bioinformatic Solutions.